Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

ClinicalTrials.gov ID: NCT00625066

Public ClinicalTrials.gov record NCT00625066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Tennessee Colorectal Polyp Study

Study identification

NCT ID
NCT00625066
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Vanderbilt University
Other
Enrollment
8,108 participants

Conditions and interventions

Interventions

  • biologic sample preservation procedure Other
  • cytology specimen collection procedure Other
  • medical chart review Other
  • questionnaire administration Other
  • survey administration Other
  • biopsy Procedure
  • evaluation of cancer risk factors Procedure
  • screening colonoscopy Procedure

Other · Procedure

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Nov 29, 2025
Completion
Nov 29, 2025
Last update posted
Dec 16, 2025

2003 – 2025

United States locations

U.S. sites
4
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Vanderbilt-Ingram Cancer Center - Cool Springs Nashville Tennessee 37064
Vanderbilt-Ingram Cancer Center at Franklin Nashville Tennessee 37064
Veterans Affairs Medical Center - Nashville Nashville Tennessee 37212
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00625066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00625066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →